[1] |
Khatri A, Wang J, Pendergast A M . Multifunctional Abl kinases in health and disease[J]. J Cell Sci, 2016,129(1):9-16.
doi: 10.1242/jcs.175521
pmid: 26729027
|
[2] |
Chevalier C, Cannet A, Descamps S , et al. ABL tyrosine kinase inhibition variable effects on the invasive properties of different triple negative breast cancer cell lines[J]. PLoS One, 2015,10(3):e0118854.
doi: 10.1371/journal.pone.0118854
pmid: 25803821
|
[3] |
Wang J, Pendergast A M . The emerging role of ABL kinases in solid tumors[J]. Trends Cancer, 2015,1(2):110-123.
doi: 10.1016/j.trecan.2015.07.004
pmid: 26645050
|
[4] |
Huang D Y, Chao Y, Tai M H , et al. STI571 reduces TRAIL-induced apoptosis in colon cancer cells: c-Abl activation by the death receptor leads to stress kinase-dependent cell death[J]. J Biomed Sci, 2012,19(1):35.
doi: 10.1186/1423-0127-19-35
|
[5] |
Greuber E K, Smith-Pearson P, Wang J , et al. Role of ABL family kinases in cancer: from leukaemia to solid tumours[J]. Nature Reviews Cancer, 2013,13(8):559-571.
doi: 10.1038/nrc3563
pmid: 23842646
|
[6] |
Do M T, Na M K, Kim H G , et al. Ilimaquinone induces death receptor expression and sensitizes human colon cancer cells to TRAIL-induced apoptosis through activation of ROS-ERK/p38 MAPK-CHOP signaling pathways[J]. Food and Chemical Toxicology, 2014,71:51-59.
doi: 10.1016/j.fct.2014.06.001
|
[7] |
Kim H B, Kim M J, Lee S H , et al. Amurensin G, a novel SIRT1 inhibitor, sensitizes TRAIL-resistant human leukemic K562 cells to TRAIL-induced apoptosis[J]. Biochemical Pharmacology, 2012,84(3):402-410.
doi: 10.1016/j.bcp.2012.03.014
|
[8] |
Sridevi P, Nhiayi M K, Setten R L , et al. Persistent inhibition of ABL tyrosine kinase causes enhanced apoptotic response to TRAIL and disrupts the pro-apoptotic effect of chloroquine[J]. PLoS One, 2013,8(10):e77495.
doi: 10.1371/journal.pone.0077495
pmid: 24147007
|
[9] |
Byeon H J, Lee C, Lee S , et al. Doxorubicin-bound albumin nanoparticles containing a TRAIL protein for targeted treatment of colon cancer[J]. Pharmaceutical Research, 2016,33(3):615-626.
doi: 10.1007/s11095-015-1814-z
pmid: 26526555
|
[10] |
Cousin F J, Jouan-Lanhouet S, Th $\acute{e}$ret N, et al. The probiotic Propionibacterium freudenreichii as a new adjuvant for TRAIL-based therapy in colorectal cancer[J]. Oncotarget, 2016,7(6):7161-7178.
doi: 10.18632/oncotarget.6881
pmid: 26771233
|
[11] |
Saturno G, Valenti M, Brandon A D H, et al. Combining TRAIL with PI3 kinase or HSP90 inhibitors enhances apoptosis in colorectal cancer cells via suppression of survival signaling[J]. Oncotarget, 2013,4(8):1185-1198.
|
[12] |
丁燕飞, 成小姣, 朱黎明 , 等. XAFl 增强 TRAIL 诱导人结肠癌细胞株 HCTl16 凋亡的实验研究[J]. 胃肠学, 2013,18(4):211-215.
|
[13] |
谭明华, 曹杰, 王辉 , 等. TRAIL 联合奥沙利铂对结肠癌细胞株 SW480 凋亡的影响[J]. 广东医学, 2008(1):34-36.
|
[14] |
Akpinar B, Bracht E V, Reijnders D , et al. 5-Fluorouracil-induced RNA stress engages a TRAIL-DISC-dependent apoptosis axis facilitated by p53[J]. Oncotarget, 2015,6(41):43679-43697.
doi: 10.18632/oncotarget.6030
pmid: 26544897
|
[15] |
Islamian J P, Aghaee F, Farajollahi A , et al. Combined treatment with 2-deoxy-D-glucose and doxorubicin enhances the in vitro efficiency of breast cancer radiotherapy[J]. Asian Pacific Journal of Cancer Prevention, 2014,16(18):8431-8438.
doi: 10.7314/apjcp.2015.16.18.8431
pmid: 26745097
|
[16] |
Zhu X F, Li W, Ma J Y , et al. Knockdown of heme oxygenase-1 promotes apoptosis and autophagy and enhances the cytotoxicity of doxorubicin in breast cancer cells[J]. Oncology Letters, 2015,10(5):2974-2980.
doi: 10.3892/ol.2015.3735
pmid: 26722274
|